Life ScienceCompany
Cumberland Pharmaceuticals M&A Summary
Cumberland Pharmaceuticals has acquired 1 company.
Cumberland Pharmaceuticals’ largest acquisition to date was in 2018, when it acquired Theravance Biopharma - VIBATIV for $20M. Cumberland Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Cumberland Pharmaceuticals Business Overview
Where is Cumberland Pharmaceuticals headquartered?
Cumberland Pharmaceuticals is headquartered in Nashville, Tennessee.
What is Cumberland Pharmaceuticals’ revenue?
Cumberland Pharmaceuticals disclosed revenue of 36M USD for 2021 and 37M USD for 2020.
How many employees does Cumberland Pharmaceuticals have?
Cumberland Pharmaceuticals has 83 employees.
What sector is Cumberland Pharmaceuticals in?
Cumberland Pharmaceuticals is a life science company.
When was Cumberland Pharmaceuticals founded?
Cumberland Pharmaceuticals was founded in 1999.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1